| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328954 Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections |
| 12/11/2001 | US6328867 Electrochemical field probe for measuring solute concentrations of elements dissolved in a liquid, such as a molten metal bath |
| 12/11/2001 | US6328851 Providing flow of paper stock, supplying paper stock to headbox, measuring flow of paper stock, conveying paper stock fromheadbox to former section in which a paper web is produced and from which white water is expelled, producing paper |
| 12/11/2001 | US6328726 Blood collecting apparatus and blood-collecting method using blood collecting apparatus |
| 12/11/2001 | US6328167 Blood filter cartridge |
| 12/11/2001 | US6327899 Device for moisture measurement in harvesting machines |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2231222C Multi-photon laser microscopy |
| 12/11/2001 | CA2221419C Method for determining dissolved oxygen in water |
| 12/11/2001 | CA2205057C Device and method for dna amplification and assay |
| 12/11/2001 | CA2162286C Method of determining the amount of cholesterol in a high-density lipoprotein |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2151741C Methods of producing analgesia and enhancing opiate analgesia |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2126636C Device improving target molecules capture; capturing process using said device |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/11/2001 | CA2053284C Method for determination of glucose in whole blood and cuvette and photometer for carrying out said method |
| 12/09/2001 | CA2349959A1 Multiple coagulation test system and method of using a multiple coagulation test system |
| 12/09/2001 | CA2311252A1 Integrated water quality monitoring system |
| 12/09/2001 | CA2309379A1 Viral variants and uses therefor |
| 12/08/2001 | CA2349777A1 Method and device for increasing efficiency of bioanalysis |
| 12/08/2001 | CA2345979A1 Probes and methods for detection of nucleic acids |
| 12/06/2001 | WO2001092990A2 Structure-based methods for assessing amino acid variances |
| 12/06/2001 | WO2001092893A1 Practical screening method for detecting genetic disorders of sterol metabolism |
| 12/06/2001 | WO2001092892A2 Methods to identify compounds that modulate rage |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092890A1 Method for the analysis of picomole amounts of carbohydrates |
| 12/06/2001 | WO2001092889A1 Low-enriched 13c-labelled urea composition for urea breath test |
| 12/06/2001 | WO2001092888A2 A method for screening and isolating microorganisms |
| 12/06/2001 | WO2001092887A1 No wash bead assay, kit and procedure |
| 12/06/2001 | WO2001092886A1 Biosensor and blood component analyzing method |
| 12/06/2001 | WO2001092885A1 Immunological latex turbidimetry method and reagent therefor |
| 12/06/2001 | WO2001092884A1 Biosensor and method for its preparation |
| 12/06/2001 | WO2001092883A2 Surface for the immobilisation of ligands |
| 12/06/2001 | WO2001092882A1 Method of detecting the presence of a liquid in a mix |
| 12/06/2001 | WO2001092881A1 Lithium detection in liquid biological samples and reagents therefor |
| 12/06/2001 | WO2001092880A2 Method for analysis of metabolic pathways |
| 12/06/2001 | WO2001092879A1 An assay method and kit for testing biological material for exposure to stress using biomarkers |
| 12/06/2001 | WO2001092878A1 Calibration method compensating for the concentration of water vapor |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092876A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 12/06/2001 | WO2001092875A1 Method and device for the recognition of impurities in a longitudinally moving thread-like product |
| 12/06/2001 | WO2001092874A1 Method for the identification of agents and genes influencing cardiovascular function |
| 12/06/2001 | WO2001092873A1 Detection system for sorting apparatus |
| 12/06/2001 | WO2001092872A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 12/06/2001 | WO2001092870A2 Kit and method for determining a plurality of analytes |
| 12/06/2001 | WO2001092869A1 Method for measuring concentrations and molecular weights of glue and gelatin |
| 12/06/2001 | WO2001092866A1 Positive identification of samples analysed by electrophoresis on a porous support |
| 12/06/2001 | WO2001092864A1 Gas detector and automobile ventilation system |
| 12/06/2001 | WO2001092859A1 Method and system for classifying a biological sample |
| 12/06/2001 | WO2001092857A2 Dual beam ftir methods and devices for analyte detection in samples of low transmissivity |
| 12/06/2001 | WO2001092855A1 Method and apparatus for prediction of the drip loss of a part of a carcass |
| 12/06/2001 | WO2001092850A1 Method and apparatus for the detection of a hidden element exuding vapor |
| 12/06/2001 | WO2001092615A2 Method for controlling a texturing machine, and texturing machine |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092579A2 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092567A2 Novel target genes for diseases of the heart |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092562A2 Inhibiting retroviral integration by targeting the atm pathway |
| 12/06/2001 | WO2001092561A2 Method of screening for negative cross resistance |
| 12/06/2001 | WO2001092560A2 Assay for kinases and phosphatases |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092521A1 Therapeutic compounds |
| 12/06/2001 | WO2001092507A1 Shedding fragments of cd44, utilization thereof and inhibition of the shedding |
| 12/06/2001 | WO2001092499A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092480A1 Method of forming vertebrate pancreas in vitro |
| 12/06/2001 | WO2001092479A2 Method to determine the differentiation potential of a target cell |
| 12/06/2001 | WO2001092477A2 Three-dimensional skin model |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092473A2 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 12/06/2001 | WO2001092338A1 Diagnosis of endometrial precancers |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092335A1 Protein complex crystals, structural coordinates and utilization of the structural coordinates |
| 12/06/2001 | WO2001092331A2 Compositions and methods for the treatment of immune related diseases |
| 12/06/2001 | WO2001092312A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092303A2 Human ion channels |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001092289A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1 |
| 12/06/2001 | WO2001092284A1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
| 12/06/2001 | WO2001092277A1 Metallocenes as signal-transducer for detection of chemical or biological events |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001091903A2 Self-contained devices for detecting biological contaminants |
| 12/06/2001 | WO2001091786A2 Diagnosis and treatment of herpes infections |
| 12/06/2001 | WO2001091699A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | WO2001091634A2 Apparatus and method for obtaining blood for diagnostic tests |
| 12/06/2001 | WO2001091629A2 Methods for detecting dna damage and screening for cancer therapeutics |
| 12/06/2001 | WO2001091626A2 Systems and methods for monitoring health and delivering drugs transdermally |
| 12/06/2001 | WO2001091625A2 Methods and compositions for the diagnosis of schizophrenia |
| 12/06/2001 | WO2001091547A1 Model animals of daily fluctuations in blood pressure and urinary sodium |